rs587784383
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_006517.5(SLC16A2):c.979G>A(p.Gly327Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006517.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A2 | ENST00000587091.6 | c.979G>A | p.Gly327Arg | missense_variant | Exon 3 of 6 | 1 | NM_006517.5 | ENSP00000465734.1 | ||
SLC16A2 | ENST00000590447.1 | c.418G>A | p.Gly140Arg | missense_variant | Exon 2 of 4 | 5 | ENSP00000466213.1 | |||
SLC16A2 | ENST00000636771.1 | n.*680G>A | non_coding_transcript_exon_variant | Exon 4 of 7 | 5 | ENSP00000490445.1 | ||||
SLC16A2 | ENST00000636771.1 | n.*680G>A | 3_prime_UTR_variant | Exon 4 of 7 | 5 | ENSP00000490445.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Allan-Herndon-Dudley syndrome Pathogenic:2
PM2_Supporting+PS4_Supporting+PP4+PM5_Supporting+PS3_Moderate -
- -
Spastic paraplegia Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 327 of the SLC16A2 protein (p.Gly327Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Allan–Herndon–Dudleysyndrome (PMID: 20083155, 23744248, 30369548). This variant is also known as Gly401Arg. ClinVar contains an entry for this variant (Variation ID: 159901). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC16A2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC16A2 function (PMID: 30369548). This variant disrupts the p.Gly327 amino acid residue in SLC16A2. Other variant(s) that disrupt this residue have been observed in individuals with SLC16A2-related conditions (PMID: 31410843), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Decreased activity of the pyruvate dehydrogenase complex Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at